Donald Wuchterl
Directeur/Membre du Conseil chez ABEONA THERAPEUTICS INC.
Fortune : 239 815 $ au 30/04/2024
Postes actifs de Donald Wuchterl
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ABEONA THERAPEUTICS INC. | Directeur/Membre du Conseil | 19/04/2021 | - |
| Independent Dir/Board Member | 19/04/2021 | - | |
| T-Knife Therapeutics, Inc. | Corporate Officer/Principal | - | - |
Historique de carrière de Donald Wuchterl
Anciens postes connus de Donald Wuchterl
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| AUDENTES THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2016 | 01/01/2021 |
Cytovance Biologics, Inc.
 Cytovance Biologics, Inc. BiotechnologyHealth Technology Cytovance Biologics, Inc. operates as a biopharmaceutical contract manufacturing company. It specializes in the production of therapeutic proteins and antibodies from both mammalian cell culture and microbial fermentation. Its services include Cell Line Selection, Cell Culture, Recovery and Purification, Analytical development, Troubleshooting Existing Processes, Final Product Fill and Finish, Technology Transfer, Microbial Fermentation, Purification, Cell banking and storage, and Project management. The company was founded in 2003 and is headquartered in Oklahoma City, OK. | Directeur des opérations | - | - |
Formation de Donald Wuchterl
| Fitchburg State University | Masters Business Admin |
| Colorado Technical University, Inc. | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 7 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
| Independent Dir/Board Member | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ABEONA THERAPEUTICS INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Astellas Gene Therapies, Inc.
 Astellas Gene Therapies, Inc. BiotechnologyHealth Technology Astellas Gene Therapies, Inc. is a biotechnology company, which engages in the development and commercialization of gene therapy products for patients with serious and rare diseases caused by single gene defects. The company was founded by Matthew R. Patterson and Thomas J. Schuetz on November 13, 2012 and is headquartered in San Francisco, CA. | Health Technology |
Cytovance Biologics, Inc.
Cytovance Biologics, Inc. BiotechnologyHealth Technology Cytovance Biologics, Inc. operates as a biopharmaceutical contract manufacturing company. It specializes in the production of therapeutic proteins and antibodies from both mammalian cell culture and microbial fermentation. Its services include Cell Line Selection, Cell Culture, Recovery and Purification, Analytical development, Troubleshooting Existing Processes, Final Product Fill and Finish, Technology Transfer, Microbial Fermentation, Purification, Cell banking and storage, and Project management. The company was founded in 2003 and is headquartered in Oklahoma City, OK. | Health Technology |
| T-Knife Therapeutics, Inc. |
- Bourse
- Insiders
- Donald Wuchterl
- Expérience
